Harmony Biosciences Holdings Free Cash Flow Generation Index
Harmony Biosciences Holdings free cash flow generation index. Harmony Biosciences Holdings (HRMY) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of $92.43 Million represents 1% of operating cash flow ($92.43 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Harmony Biosciences Holdings (2021–2025)
Free cash flow generation index of Harmony Biosciences Holdings from 2021 to 2025. Historical FCF Generation Index trend for Harmony Biosciences Holdings across 5 annual periods. See Harmony Biosciences Holdings financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Harmony Biosciences Holdings Free Cash Flow Generation Index by Year (2021–2025)
Harmony Biosciences Holdings free cash flow generation index by year from 2021 to 2025. Year-by-year Free Cash Flow Generation Index for Harmony Biosciences Holdings. For the full cash flow conversion analysis, see HRMY cash generation efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $347.89 Million | $348.20 Million | $310.00K | ▲ +0.4% |
| 2024 | 0.99x | $218.67 Million | $219.82 Million | $1.15 Million | ▼ -0.4% |
| 2023 | 1.00x | $219.07 Million | $219.39 Million | $312.00K | ▼ 0.0% |
| 2022 | 1.00x | $144.29 Million | $144.47 Million | $172.00K | ▲ +0.2% |
| 2021 | 1.00x | $98.26 Million | $98.56 Million | $298.00K | — |